Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 7/2008

01-09-2008

An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey

Auteurs: Angela Buchholz, Anneke Krol, Fred Rist, Pythia T. Nieuwkerk, Gerard M. Schippers

Gepubliceerd in: Quality of Life Research | Uitgave 7/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Aims

To confirm the factorial structure of the Short Form 36 Health Survey (SF-36) in problem drug users and to compare their health-related quality of life (HRQOL) with general Dutch population norms.

Method

Data of 394 participants from the Amsterdam Cohort Study among drug users, who had completed once the SF-36 standard form (4 weeks recall) between February and August 2005, were analyzed. The factorial structure of the SF-36 was investigated by confirmatory factor analysis. Subsequently, sum scores of the eight SF-36 health dimensions were converted into z-scores by standardizing them with the mean and standard deviation of the corresponding general Dutch population age and gender group.

Results

The factor structure was acceptable and also comparable with previous findings. Compared with the general population, participants had significantly lower z-scores on all of the eight SF-36 dimensions, with largest deviations in social functioning (M = −1.13) and mental health (M = −1.01), and smallest deviations in bodily pain (M = −0.32).

Conclusion

The results corroborate the factorial structure and reliability of the answers of problem drug users to the SF−36. Their HRQOL was low, even though it was assessed irrespective of substance abuse treatment settings.
vorige artikel Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing
volgende artikel How consistent are health utility values?
Literatuur
1.
European Monitoring Centre for Drugs and Drug Addiction (2007). Annual Report 2007 Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
2.
McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness Implications for treatment, insurance and outcomes evaluation. JAMA, 284, 1689–1695.PubMedCrossRef
3.
Connor, J. P., Saunders, J. B., & Feeney, G. F. X. (2006). Quality of life in substance use disorders. In H. Katschnig, H. Freeman & N. Sartorius (Eds.), Quality of life in mental disorders (2nd ed., pp. 199–208). Chichester: Wiley.
4.
Deering, D., Frampton, C., Horn, J., Sellman, D., Adamson, S., & Potiki, T. (2004). Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire. Drug and Alcohol Review, 23, 273–280.PubMedCrossRef
5.
Smith, K. W., & Larson, M. J. (2003). Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. American Journal of Drug and Alcohol Abuse, 29, 323–335.PubMedCrossRef
6.
Stein, M. D., Mulvey, K. P., Plough, A., & Samet, J. H. (1998). The functioning and well being of persons who seek treatment for drug and alcohol use. Journal of Substance Abuse, 10, 75–84.PubMedCrossRef
7.
Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., et al. (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health, 95, 99–103.
8.
Ryan, C. F., & White, J. M. (1996). Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction, 91, 39–45.PubMedCrossRef
9.
Richter, D., Eikelmann, B., & Berger, K. (2004). Use of the SF-36 in the evaluation of a drug detoxification program. Quality of Life Research, 13, 907–914.PubMedCrossRef
10.
Neale, J. (2004). Measuring the health of Scottish drug users. Health & Social Care in the Community, 12, 202–211.CrossRef
11.
Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002). Quality of life measurement: Bibliographic study of patient assessed health outcome measures. BMJ, 324, 1417.PubMedCrossRef
12.
Ware, J. E., Jr. (2004). SF-36 health survey update. In M.E. Maruish (Ed.), The use of psychosocial testing for treatment planning and outcome assessment (3 ed., pp. 695–720). Lawrence Erlbaum Associates).
13.
Coons, S. J., Rao, S., Keininger, D. L., & Hays, R. D. (2000). A comparative review of generic quality-of-life instruments. Pharmacoeconomics, 17, 13–35.PubMedCrossRef
14.
Ware, J. E., Jr., Kosinski, M., Gandek, B., Aaronson, N. K., Apolone, G., Bech, P., et al. (1998). The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1159–1165.PubMedCrossRef
15.
Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36 Health Survey. Manual & Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Center.
16.
Ware, J. E., & Kosinski, M. (2001). Interpreting SF-36 summary health measures: A response. Quality of Life Research, 10, 405–413.PubMedCrossRef
17.
Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10, 395–404.PubMedCrossRef
18.
Taft, C., Karlsson, J., & Sullivan, M. (2001). Editorial comment: Reply to Drs Ware and Kosinski. Quality of Life Research, 10, 415–420.CrossRef
19.
Simon, G. E., Revicki, D. A., Grothaus, L., & VonKorff, M. (1998). SF-36 summary scores: Are physical and mental health truly distinct? Medical Care, 36, 567–572.PubMedCrossRef
20.
Keller, S. D., Ware, J. E., Jr., Bentler, P. M., Aaronson, N. K., Alonso, J., Apolone, G., et al. (1998). Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1179–1188.PubMedCrossRef
21.
Haynes, S. N., Nelson, K., & Blaine, D. D. (1999). Psychometric issues in assessment research. In P. C. Kendall, J. N. Butcher & G. N. Holmbeck (Eds.), Handbook of research methods in clinical psychology (2nd ed., pp. 125–154). New York: John.
22.
Messick, S. (1995). Validity of psychological assessment: Validation of inferences from persons’ responses and performances as scientific inquiry into score meaning. American Psychologist, 50, 741–749.CrossRef
23.
Reno, R. R., & Aiken, L. S. (1993). Life activities and life quality of heroin addicts in and out of methadone treatment. International Journal of the Addictions, 28, 211–232.PubMed
24.
Aiken, L. S. (1986). Retrospective self-reports by clients differ from original reports: Implications for the evaluation of drug treatment programs. International Journal of the Addictions, 21, 767–788.PubMed
25.
van den Hoek, J. A., Coutinho, R. A., van Haastrecht, H. J., van Zadelhoff, A. W., & Goudsmit, J. (1988). Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS, 2, 55–60.PubMedCrossRef
26.
Aaronson, N. K., Muller, M., Cohen, P. D., Essink-Bot, M. L., Fekkes, M., Sanderman, R., et al. (1998). Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Journal of Clinical Epidemiology, 51, 1055–1068.PubMedCrossRef
27.
Langendam, M. W., van Haastrecht, H. J., & van Ameijden, E. J. (1999). The validity of drug users’ self-reports in a non-treatment setting: Prevalence and predictors of incorrect reporting methadone treatment modalities. International journal of Epidemiology, 28, 514–520.PubMedCrossRef
28.
Sijtsma, K., & van der Ark, L. A. (2003). Investigation and treatment of missing item scores in test and questionnaire data. Multivariate Behavioral Research, 38, 505–528.CrossRef
29.
van Ginkel, J. R., & van der Ark, L. A. (2005). SPSS syntax for missing value imputation in test and questionnaire data. Applied Psychological Measurement, 29, 152–153.CrossRef
30.
Muthèn, L. K., & Muthèn, B. O. (2006). Mplus 4.1. Los Angeles: Muthèn & Muthèn.
31.
Glöckner-Rist, A., & Hoijtink, H. (2003). The best of both worlds: Factor analysis of dichotomous data using item response theory and structural equation modeling. Structural Equation Modeling, 10, 544–565.CrossRef
32.
Flora, D. B., & Curran, P. J. (2004). An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychological Methods, 9, 466–491.PubMedCrossRef
33.
Finney, S. J., & DiStefano, C. (2006). Nonnormal and categorical data in structural equation modeling. In G. R. Hancock & R. O. Mueller (Eds.), Structural equation modeling. A second course (pp. 269–314). Greenwich, Conneticut: Information Age.
34.
Marsh, H. W., Hau, K.-T., & Grayson, D. (2005). Goodness of fit in structural equation models. In A. Maydeu-Olivares & J. J. McArdle (Eds.), Contemporary psychometrics (pp. 275–340). Mahwah, NJ: Lawrence Erlbaum
35.
Brown, M. W., & Cudeck, R. (1993). Alternative ways of assessing model fit. In K. A. Bollen & J. S. Long (Eds.), Testing structural equation models (pp. 136–162). Newbury Park, CA: Sage.
36.
Wirtz, M. (2004). Über das Problem fehlender Werte: Wie der Einfluss fehlender Informationen auf Analyseergebnisse entdeckt und reduziert werden kann. [On the problem of missing data: How to identify and reduce the impact of missing data on findings of data analysis]. Rehabilitation, 43, 109–115.PubMedCrossRef
37.
Cohen, J. (1988). Statistical power analysis for the social sciences. Hillsdale, New Jersey: Lawrence Erlbaum.
38.
Bollen, K. A. (1989). Structural equations with latent variables. New York: Wiley.
39.
Reed, P. J. (1998). Medical outcomes study short form 36: Testing and cross-validating a second-order factorial structure for health system employees. Health Services Research, 33, 1361–1380.PubMed
40.
Maurischat, C., Bestmann, A., Hasenbein, U., & Bullinger, M. (2004). Strukturelle Validität des Short Form 36 Health Survey (SF-36) bei neurologischen Patienten [Structural validity of the Short Form 36 (SF-36) in patients with neurological diseases]. Neurologie & Rehabilitation, 10, 13–20.
41.
Vandenberg, R. J., & Lance, C. E. (2000). A review and synthesis of the measurement invariance literature: Suggestions, practices, and recommendations for organizational research. Organizational Research Methods, 3, 4–70.CrossRef
42.
Cheung, G. W., & Rensvold, R. B. (1999). Testing factorial invariance across groups: A reconceptualization and proposed new method. Journal of Management, 25, 1–27.CrossRef
43.
Morgan, T. J., Morgenstern, J., Blanchard, K. A., Labouvie, E., & Bux, D. A. (2003). Health related quality of life for adults participating in outpatient substance abuse treatment. The American Journal on Addictions, 12, 198–210.PubMedCrossRef
44.
Cortina, J. M. (1993). What is coefficent alpha? An examination of theory and applications. Journal of Applied Psychology, 78, 98–104.CrossRef
45.
Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., & Alonso, J. (1997). Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction, 92, 707–716.PubMedCrossRef
46.
Rose, M. S., Koshman, M. L., Spreng, S., & Sheldon, R. (1999). Statistical issues encountered in the comparison of health-related quality of life in diseased patients to published general population norms: Problems and solutions. Journal of Clinical Epidemiology, 52, 405–412.PubMedCrossRef
47.
Compton, M. A. (1994). Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status. Journal of Pain and Symptom Management, 9, 462–473.PubMedCrossRef
48.
Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90, 91–96.PubMedCrossRef
49.
Compton, P., Charuvastra, V. C., Kintaudi, K., & Ling, W. (2000). Pain responses in methadone-maintained opioid abusers. Journal of Pain and Symptom Management, 20, 237–245.PubMedCrossRef
50.
Ho, A., & Dole, V. P. (1979). Pain perception in drug-free and in methadone-maintained human ex-addicts. Proceedings of the Society for Experimental Biology and Medicine, 162, 392–395.PubMed
Metagegevens
Titel
An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey
Auteurs
Angela Buchholz
Anneke Krol
Fred Rist
Pythia T. Nieuwkerk
Gerard M. Schippers
Publicatiedatum
01-09-2008
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2008
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-008-9371-0

Andere artikelen Uitgave 7/2008

Quality of Life Research 7/2008 Naar de uitgave

Brief Communication

Statistical methodology is crucial in prognostic factor analysis of health-related quality of life

OriginalPaper

Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing

OriginalPaper

Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece

Letter to the Editor

In reply to Mauer et al. “Statistical methodology is crucial in prognostic factor-analysis of health-related quality of life”

Erratum

Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing

OriginalPaper

Exploring response shift in the quality of life of healthy adolescents over 1 year